We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Immunopurification Technique Enables Accurate Determination of Mitochondrial Metabolites

By LabMedica International staff writers
Posted on 14 Sep 2016
A rapid immunopurification technique was used to isolate mitochondria with metabolite contents that were relatively undamaged by enzyme activity and free from components of other cellular organelles.

While metabolite profiling by mass spectrometry has been widely applied for research purposes at the whole-cell level, it is not routinely possible to measure the concentrations of small molecules in mammalian organelles. More...
However, in a recent development in this field, investigators at the Whitehead Institute (Cambridge, MA, USA) have developed a method for the rapid and specific isolation of mitochondria that allows accurate quantification of this organelle's metabolite content.

Up to now, various methods of differential centrifugation have been used to isolate mitochondria. Unfortunately, these protocols also precipitate non-mitochondrial material and other organelles. In addition, these relatively lengthy procedures promote enzymatic modifications of mitochondrial metabolites that lead to variable results.

The investigators described a novel immunopurification technique for isolation of mitochondria in the August 25, 2016, issue of the journal Cell. The method was based on antibody-covered beads that bound to specific mitochondrial surface markers. Recovery of antibody-bead-mitochondria complexes permitted rapid disruption of the mitochondria and inhibition of all enzymatic activity within 10 minutes. The immunopurification technique was used it in tandem with a database of predicted mitochondrial metabolites ("MITObolome") to measure the matrix concentrations of more than 100 metabolites across various states of mitochondrial respiratory chain (RC) function.

"The advantage of this new method is that it offers a combination of both increased speed and specificity," said senior author Dr. David Sabatini, professor of biology at the Whitehead Institute. "We are quite excited about applying this workflow in vivo and to other organelles such as lysosomes."

Related Links:
Whitehead Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Portable POCT Blood Gas Analyzer
BD100
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.